Viracta Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRX and other ETFs, options, and stocks.

About VIRX

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. 

CEO
Mark A. Rothera
CEOMark A. Rothera
Employees
24
Employees24
Headquarters
Cardiff, California
HeadquartersCardiff, California
Founded
1998
Founded1998
Employees
24
Employees24

VIRX Key Statistics

Market cap
69.52M
Market cap69.52M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
98.48K
Average volume98.48K
High today
$1.96
High today$1.96
Low today
$1.80
Low today$1.80
Open price
$1.91
Open price$1.91
Volume
109.31K
Volume109.31K
52 Week high
$5.75
52 Week high$5.75
52 Week low
$1.80
52 Week low$1.80

VIRX Earnings

-$5.22
-$3.48
-$1.74
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 15, After Hours
ActualExpected Mar 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.